参考文献/References:
[1] Stone JH，Zen Y.Deshpande V. IgG4-related disease [J]. N
Engl J Med, 2012, 366: 539-551.
[2] 袁松英，朱德茂，文秋元，等. IgG4相关性硬化性脑膜炎
临床及病理特点（附8例报告）[J]. 医学临床研究，2011，
28（12）：2269-2271.
[3] Lin CK, Lai DM. IgG4-related intracranial hypertrophic
pachymeningitis with skull hyperostosis: a case report [J].
BMC Surg, 2013, 13: 37.
[4] Kamisaw T, Funata N, Hayashi Y, et al. A new clinicopatho-
logical entity of IgG4-related autoimmune disease [J]. J
Gastroenterol, 2003, 38(10): 982-984.
[5] Takahashi H, Yamamoto M, Suzuki C, et al. The birthday of
a new syndrome: IgG4-related disease constitute a clinical
entity [J]. Autoimmun Rev, 2010, 9: 591-594.
[6] Chan SK, Cheuk W, Chan KT, et al. IgG4-related sclerosing
pachyrneningitis: a previously unrecognized form of central
nervous system involvement in IgG4-related sclerosing
disease [J]. Am J Surg Pathol, 2009, 33(8): 1249-1252.
[7] Takeuchi S, Osada H, Seno S, et al. IgG4-related intracranial
hypertrophic pachymeningitis: a case report and review of
the literature [J]. J Korean Neurosurg Soc, 2014, 55(5): 300-
302.
[8] Lu LX, Della-Torre E, Stone JH, et al. IgG4-related
hypertrophic pachymeningitis: clinical features, diagnostic
criteria, and treatment [J]. JAMA Neurol, 2014, 71(6):
785-793.
[9] Wallace ZS, Carrathers MN, Khosroshahi A, et al. IgG4-
related disease and hypertrophic pachymeningitis [J].
Medicine (Baltimore), 2013, 92(4): 206-216.
[10] Yonekawa T, Murai H, Utsuki S, et al. A nationwide survey
of hypertrophic pachymeningitis in Japan [J]. J Neural
Neurosurg Psychiatry, 2014, 85(7): 732-739.
[11] Catruthers R, Carruthers M, Della-Torre E. IgG4-related
disease and other causes of inflammatory meningeal disease
[J]. Semin Neurol, 2014, 34(4): 395-404.
[12] Mahajan VS, Mattoo H, Deshpande V, et al. IgG4-related
disease [J]. Annu Rev Pathol, 2014, 9: 315-347.
[13] Mattoo H, Mahajan VS, Della-Torre E, et al. De novo
oligoclonal expansions of circulating plasmablasts in active
and relapsing IgG4-related disease [J]. J Allergy Clin
Immunol, 2014, 134 (3): 679-687.
[14] Della-Torre E, Passerini G, Furlan R, et al. Cerebrospinal
fluid analysis in immunoglobulin IgG4-related hypertrophic
pachymeningitis [J]. J Rheumatol, 2013, 40: 1927-1929.
[15] 倪海春，朴月善，卢德宏，等. IgG4相关特发性肥厚性硬
脑膜炎：一例报告并文献复习[J]. 中国现代神经疾病杂
志，2011，11（5）：529-533.
[16] Zhu R, He Z, Ren Y, et al. Idiopathic hypertrophic crani
cervical pachymeningitis [J]. Eur Spine J, 2015, 24(Suppl
4): s633-s635.
[17] Roche JC, S??nchez-Carteyron A, Mincholé E, et al. Reply:
Idiopathic hypertrophic pachymeningitis mimicking neuro-
sarcoidosis [J]. Clin Neurol Neurosurg, 2012, 114(6): 825-
826.
[18] Kim EH, Kim SH, Cho JM, et al. Immunoglobulin IgG4-
related hypertrophic pachymeningitis involving cerebral
parenchyma [J]. J Neurosurg, 2011, 115(6): 1242-1247.
[19] Lu Z, Tongxi L, Jie L, et al. IgG4-related spinal pachyme-
ningitis [J]. Clin Rheumatol, 2016, 35(6): 1549-1553.
[20] 孙 玮，董凌莉，高荣芬，等. IgG4相关性疾病[J]. 中华风
湿病学杂志，2012，16（12）：835-838.
[21] Della-Torre E, Galli L, Franciotta D, et al. Diagnostic value
of IgG4 Indices in IgG4-related hypertrophic pachymenin-
gitis [J]. J Neuroimmun, 2014, 266(1-2): 82-86.
[22] Umehara H, Okazaki K, Masaki Y, et al. Comprehensive
diagnostic criteria for IgG4-related disease (IgG4-RD),
2011 [J]. Mod Rheumatol, 2012, 22(1): 21-30.
[23] Deshpande V, Zen Y, Chan JK, et al. Consensus statement
on the pathology of IgG4-related disease [J]. Mod Pathol,
2012, 25 (9): 1181-1192.
[24] 王育波，彭 涛，别 黎，等. 富于淋巴细胞浆细胞型脑膜
瘤临床研究进展[J]. 中华医学杂志，2013，93（17）：1354-
1355.
[25] 张安莉，孙思柏，丁 敏，等. 脊索样脑膜瘤7例临床病理
分析[J]. 临床与实验病理学杂志，2016，32（3）： 341-343，
346.
[26] 丁 鑫，焦彦超，吕 彦，等. 原发颅内孤立性Rosai-
Dorfman病1例及文献复习[J]. 中国神经精神疾病杂志，
2015，41（2）：70.
[27] Hart PA, Topazian MD, Witzig TE, et al. Treatment of repla-
psing autoimmune pancreatitis with immunomodulators and
rituximab: the Mayo Clinic experience [J]. Gut, 2012, 62
（11）: 1607-1615.
[28] Kamisawa T, Okazaki K, Kawa S, et al. Japanse consensus
guidelines for management of autoimmune pancreatitis: Ⅲ.
Treatment and prognosis of AIP [J]. L Gastroenterol, 2010,
45（5）: 471-477.